Clinical Trial Update: Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating venetoclax and azacitidine with homoharringtonine, followed by allogeneic hematopoietic stem cell transplantation, for inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Homoharringtonine (homoharringtonine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING